grepcent public filings, reorganized for comparison

GLSI profile · all as-reported value updates

Greenwich LifeSciences, Inc. (GLSI) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

GLSI as-reported XBRL value updates. Compact figure; full filing links are in the page table.GLSI as-reported XBRL value updates. Compact figure; full filing links are in the page table.MetricFYThenNowDeltaDelta %Stockholders' equity2024$2.5M$908.6K-$1.6M-64.14%Liabilities2024$1.6M$3.2M$1.6M+51.03%Net income2024-$15.8M-$17.4M-$1.6M-9.33%Operating income2024-$16.0M-$17.6M-$1.6M-9.22%
MetricFYEarliest XBRL-filed valueCurrently on fileDifferenceDifference %LabelFiling linksNotes
Stockholders' equity
StockholdersEquity
20242,534,036
filed 2025-04-15 · 10-K
908,626
filed 2026-06-01 · 10-K
-1,625,410-64.14%revised comparative figure0001641172-25-004819
0001493152-26-026651
2 filed observations examined for this concept and period.
Liabilities
Liabilities
20241,559,733
filed 2025-04-15 · 10-K
3,185,143
filed 2026-06-01 · 10-K
1,625,410+51.03%revised comparative figure0001641172-25-004819
0001493152-26-026651
2 filed observations examined for this concept and period.
Net income
NetIncomeLoss
2024-15,788,809
filed 2025-04-15 · 10-K
-17,414,219
filed 2026-06-01 · 10-K
-1,625,410-9.33%revised comparative figure0001641172-25-004819
0001493152-26-026651
2 filed observations examined for this concept and period.
Operating income
OperatingIncomeLoss
2024-16,011,817
filed 2025-04-15 · 10-K
-17,637,227
filed 2026-06-01 · 10-K
-1,625,410-9.22%revised comparative figure0001641172-25-004819
0001493152-26-026651
2 filed observations examined for this concept and period.